Unique Imaging Edge Target radiology departments and breast clinics seeking non-ionizing, comprehensive imaging for dense breasts. The SoftVue ring transducer and triple acoustic detection differentiate the system, enabling partnerships that enhance diagnostic accuracy and patient experience.

Funding to Scale Recent funding activity and leadership additions signal readiness to accelerate commercialization and field deployment. With focused product and market leadership, there are opportunities to engage large hospital systems, academic medical centers, and imaging networks.

Regulatory Credibility FDA clearance for diagnostic imaging and industry recognition strengthen procurement conversations with radiology leadership. Leverage awards and recognition to support clinical studies, reference sites, and market penetration efforts.

Differentiated Offering The system provides a complementary imaging solution to traditional screening, appealing to centers focused on patient safety and comfort. Potential to cross-sell within breast imaging workflows and integrate with radiology information systems to improve throughput.

Global Expansion Potential A staged global commercialization strategy and growth capital create opportunities to partner with distributors and international healthcare networks. Target international breast imaging programs, clinical research sites, and public or private sector procurement channels.